Rockefeller Capital Management
TCRT icon

Rockefeller Capital Management’s Alaunos Therapeutics TCRT Stock Holding History

Rockefeller Capital Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-56
Closed -$5K – 3690
2022
Q4 		$5K Hold
56
– – ﹤0.01% 3345
2022
Q3 		$14K Hold
56
– – ﹤0.01% 2943
2022
Q2 		$10K Buy
56
+49
+700% +$4.68K ﹤0.01% 3134
2022
Q1 		$0 Hold
7
– – ﹤0.01% 4059
2021
Q4 		$1K Hold
7
– – ﹤0.01% 3693
2021
Q3 		$1K Hold
7
– – ﹤0.01% 3622
2021
Q2 		$2K Hold
7
– – ﹤0.01% 3275
2021
Q1 		$3K Buy
+7
New +$4.36K ﹤0.01% 3053
2020
Q4 		– Sell
-102
Closed -$38K – 3003
2020
Q3 		$38K Sell
102
-78
-43% -$34.5K ﹤0.01% 1594
2020
Q2 		$89K Buy
180
+155
+620% +$69.1K ﹤0.01% 1206
2020
Q1 		$9K Buy
+25
New +$12.9K ﹤0.01% 1780

Other funds holding TCRT

DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Rockefeller Capital Management's TCRT Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Alaunos Therapeutics (TCRT) in Q1 2023, closing a stake of 56 shares — an estimated $5K sold.

Rockefeller Capital Management first reported a position in TCRT in Q1 2020 and held it in 11 quarters. The position peaked at $89K in Q2 2020. 108 funds tracked by Wall St. Rank hold TCRT as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Alaunos Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 56 Alaunos Therapeutics shares in Q1 2023, an estimated $5K.
  • Rockefeller Capital Management first reported a position in Alaunos Therapeutics in Q1 2020 and held it in 11 quarters.
  • Rockefeller Capital Management's Alaunos Therapeutics position peaked at $89K in Q2 2020.
  • 108 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.